Treatment of HR+/HER2− breast cancer in urban mainland China: results from the CancerMPact Survey 2019

PURPOSE: To report the treatment utilization patterns for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) breast cancer in urban mainland China (CancerMPact®). METHODS: The results presented are from an online survey conducted in September 2019 with 45 physi...

Descripción completa

Detalles Bibliográficos
Autores principales: Murali, Bhavna, Durbin, Laura, Vijaykumar, Sapna, Yang, Linda, Li, Song, Zhao, Linda, Hawthorne, Stephanie, Kanas, Gena, Davis, Christine, Clark, Otávio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464725/
https://www.ncbi.nlm.nih.gov/pubmed/35986800
http://dx.doi.org/10.1007/s10549-022-06709-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464725/
https://www.ncbi.nlm.nih.gov/pubmed/35986800
http://dx.doi.org/10.1007/s10549-022-06709-x

Ejemplares similares